KIMS
NIFTY500
Krishna Institute of Medical Sciences Ltd.
Pharma · NSE
₹717.60
1Y+8.3%
52-week range
₹576 – ₹798
From 52w high
-10.1%
RSI (14)
66.8
vs SMA 50 / 200
↑ 50 · ↑ 200
PE
103.3
Forward PE
60.8
ROE
—
Profit margin
8.3%
D/E
123.72
Dividend yield
—
Quality score
17/100
Revenue growth
29.2%
Earnings growth
-40.1%
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.